Text Size

Management of inflammation in dry eye disease: Recommendations from a European panel of experts

Messmer EM, Ahmad S, Benitez del Castillo JM, Mrukwa-Kominek E, Rolando M, Vitovska O, Baudouin C, On behalf of a panel of European Dry Eye Disease experts


  • 2022
  • European Journal of Ophthalmology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Department of Ophthalmology, Ludwig Maximilian University, Munich, Germany; 4960Moorfields Eye Hospital NHS Foundation Trust, London, UK; Hospital Clínico San Carlos, Complutense University of Madrid, Clínica Rementería, Madrid, Spain; Department of Ophthalmology, 49613Medical University of Silesia, Katowice, Poland; Department of Ophthalmology, 9302University of Genoa, Genoa, Italy; National Medical University 'O.O. Bogomolec', Kiev, Ukraine; Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital and Vision Institute, Paris, France.

Related Publications

Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.


Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022